Zydus Life is buy for TP of ₹1439 (30% upside from CMP)

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Aug 27, 2024.

Tags:
Previous Thread Next Thread
Loading...
  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    972
    Likes Received:
    55
    Zydus Life is out of favour due to its acquisition of 50% stake in Sterling Biotech. Some experts say this is a buying opportunity given the strong fundamentals of Co. KR Choksey has recommended buy for TP of ₹1439 (30% upside from CMP). In any case, short-term bounce is likely

    [​IMG]

    [​IMG]
     
    Vidhi Khanna, Aug 27, 2024
    #1
Previous Thread Next Thread
Loading...
Loading...
Similar Threads
  1. Vidhi Khanna

    Reverse merger approval of Axis Max Life is a key catalyst to unlock value. Target Price ₹1850 +15%

    Vidhi Khanna, Jun 29, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    246
    Vidhi Khanna
    Jun 29, 2025
  2. Vidhi Khanna

    Raymond Lifestyle's valuation, after the correction, appears attractive. TP ₹1500 (+49%)

    Vidhi Khanna, May 14, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    379
    Vidhi Khanna
    May 14, 2025
  3. Vidhi Khanna

    HDFC LIFE is top pick. Target Price ₹900 (25%)

    Vidhi Khanna, Apr 19, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    415
    Vidhi Khanna
    Apr 19, 2025
  4. Vidhi Khanna

    Raymond Lifestyle has multiple growth drivers. Target Price ₹3000 (+49%)

    Vidhi Khanna, Dec 27, 2024, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    774
    Vidhi Khanna
    Dec 27, 2024
  5. Vidhi Khanna

    Mukul Agrawal has invested ₹45 Cr in 1.58% of Stanley Lifestyle

    Vidhi Khanna, Oct 21, 2024, in forum: Portfolios Of Famous Investors
    Replies:
    0
    Views:
    748
    Vidhi Khanna
    Oct 21, 2024